NCT02069730 2026-01-08A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of GenesUniversity Health Network, TorontoPhase NA Completed114 enrolled
NCT01859026 2023-01-19A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR MutationH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed43 enrolled